Dr. Devendra N. Amin, MD

Dr. Amin practices at Morton Plant Hospital in Clearwater, Florida, part of BayCare Health System.

Dr. Amin's NPI, 1508847070, was assigned on November 10, 2005. Dr. Amin graduated from Guy's, King's and St Thomas' School of Medical Education in 1981. Dr. Amin holds Florida license ME0057186.

Dr. Amin's primary practice is Morton Plant Hospital, at 300 Pinellas St, Clearwater, FL 33756 in Pinellas County. The practice phone is (727) 462-7000.

Dr. Amin's primary practice is Morton Plant Hospital in Clearwater, Florida, part of BayCare Health System. Dr. Amin is also affiliated with BayCare Mease Countryside Hospital. The medical group on file is BayCare Medical Group. Dmand AI also links Dr. Amin to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amin practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Amin's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Amin is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Amin's licenses on file in 2 states: Florida and New York.

Dmand AI lists acute respiratory failure, chronic respiratory failure, lung disease: COPD, asthma or bronchitis, pneumonia and respiratory infection and tobacco use among the conditions Dr. Amin treats.

CMS data shows 892 Medicare services from Dr. Amin across 8 procedure codes in 2024, for 298 Medicare patients. Medicare paid $100,092 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 298 Medicare patients who saw Dr. Amin in 2024. The largest group is 65 to 74, with 110 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Amin's median patient age at 73, with 48% women.

In 2018, Dr. Amin wrote 16 Medicare Part D claims. They cover 1 drug, with $151,258 in total drug cost. In 2017, CMS named 219 claims across 8 drugs.

Dr. Amin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 28 papers to Dr. Amin, published from 2012 to 2024. 2016 was the busiest year, with 5. The most frequent topics are Calcitonin, Protein Precursors and Calcitonin Gene-Related Peptide. Dr. Amin has published most often in Crit Care. Dr. Amin's most frequent co-authors are Matthew M. Churpek, MD, PhD, Majid Afshar, MD and Brian William Patterson, MD.

Dmand AI links Dr. Amin to 2 clinical trials. Conditions studied include Idiopathic Pulmonary Fibrosis, Pulmonary Arterial Hypertension and Hypertension, Pulmonary.

CMS Open Payments shows 121 general payments to Dr. Amin from 27 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 51% of the total. bioMerieux paid the most, $119,315.

Dmand AI lists 2 awards for Dr. Amin, most recently CMS Stage 1 EHR in 2013.

Dr. Amin graduated from Guy's, King's and St Thomas' School of Medical Education in 1981. Dr. Amin is a member of SCCM.

Dr. Amin is in network with 11 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.